Residual Specimen Program FAQ

Interested in our Residual Specimen Program and have some questions? Download more information now.

Notable’s Residual Specimens Program is a collaboration with key clinical diagnostic partners who are sampling bone marrow or peripheral blood for diagnostic purposes. The remaining, unused portion of the sample is sent to Notable to evaluate drug sensitivity to further individualized drug development for hematological cancers via our cutting edge predictive technology platform.